OTCMKTS:MAQAF Atlas Arteria (MAQAF) Stock Price, News & Analysis → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free MAQAF Stock Alerts $3.72 +0.13 (+3.48%) (As of 05/10/2024 01:47 PM ET) Add Compare Share Share Today's Range$3.69▼$3.7250-Day Range$3.17▼$3.7252-Week Range$3.17▼$4.44Volume7,478 shsAverage Volume3,440 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield2.23%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Atlas Arteria alerts: Email Address Atlas Arteria MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearishDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment-0.76Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.00 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Atlas Arteria.Read more about Atlas Arteria's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverAtlas Arteria has a short interest ratio ("days to cover") of 1013.5, which indicates bearish sentiment.Change versus previous monthShort interest in Atlas Arteria has recently increased by 28.06%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend LeadershipAtlas Arteria is a leading dividend payer. It pays a dividend yield of 5.02%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAtlas Arteria does not have a long track record of dividend growth.Read more about Atlas Arteria's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MAQAF. Previous Next 0.7 News and Social Media Coverage News SentimentAtlas Arteria has a news sentiment score of -0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Industrials companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Atlas Arteria this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Atlas Arteria insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 24.06% of the stock of Atlas Arteria is held by institutions.Read more about Atlas Arteria's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Atlas Arteria is -36.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Atlas Arteria is -36.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Atlas Arteria Stock (OTCMKTS:MAQAF)Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.Read More MAQAF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MAQAF Stock News HeadlinesMay 8, 2024 | afr.comAtlas Arteria’s ‘back-up plan’ to fight French taxesMarch 25, 2024 | finance.yahoo.comAtlas Arteria Ltd's Dividend AnalysisMay 11, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.February 29, 2024 | finance.yahoo.comAtlas Arteria Full Year 2023 Earnings: EPS: AU$0.22 (vs AU$0.25 in FY 2022)February 7, 2024 | afr.comAtlas Arteria’s 40pc Washington DC toll rise proposal hits dead endJanuary 31, 2024 | markets.businessinsider.comMacquarie Reaffirms Their Hold Rating on Atlas Arteria (MAQAF)December 16, 2023 | finance.yahoo.comWith 78% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional ownersNovember 8, 2023 | morningstar.comAtlas Arteria Ltd MAQAFMay 11, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.November 7, 2023 | afr.comIFM Investors creeps up Atlas Arteria’s register; Jarden on ticketOctober 3, 2023 | markets.businessinsider.comAtlas Arteria (MAQAF) Receives a Hold from RBC CapitalSeptember 27, 2023 | afr.comAtlas Arteria to fight new French motorway taxesSeptember 26, 2023 | finance.yahoo.comBullish Atlas Arteria Insiders Loaded Up On AU$1.3m Of StockSeptember 7, 2023 | finance.yahoo.comMAQAF - Atlas Arteria LimitedSeptember 1, 2023 | markets.businessinsider.comRBC Capital Sticks to Its Hold Rating for Atlas Arteria (MAQAF)July 4, 2023 | markets.businessinsider.comRBC Capital Sticks to Their Hold Rating for Atlas Arteria (MAQAF)June 17, 2023 | finance.yahoo.comWith 80% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional ownersMay 30, 2023 | afr.com$9b tollroads group Atlas Arteria hit with first strikeMay 3, 2023 | afr.comIFM Investors creeps up at Atlas Arteria, Jarden trades $197m lineFebruary 27, 2023 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on Atlas Arteria (MAQAF)February 24, 2023 | finance.yahoo.comAtlas Arteria Full Year 2022 Earnings: Misses ExpectationsFebruary 23, 2023 | afr.comAtlas Arteria to bypass EastLink saleFebruary 22, 2023 | afr.comAtlas Arteria’s annual profits jump 47pc on traffic reboundJanuary 29, 2023 | markets.businessinsider.comABN Amro Reaffirms Their Hold Rating on Atlas Arteria (MAQAF)January 7, 2023 | finance.yahoo.comWith 81% ownership of the shares, Atlas Arteria Limited (ASX:ALX) is heavily dominated by institutional ownersDecember 19, 2022 | afr.comIFM adviser Ken Daley to join Atlas Arteria boardNovember 24, 2022 | markets.businessinsider.comPositive Report for Atlas Arteria (MAQAF) from RBC CapitalSee More Headlines Receive MAQAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Infrastructure Operations Sub-IndustryN/A Current SymbolOTCMKTS:MAQAF CUSIPN/A CIKN/A Webwww.atlasarteria.com Phone611800621694FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Graeme Francis Bevans (Age 66)MD, CEO & Executive Director Comp: $1.8MMr. David CollinsChief Financial OfficerMr. Vincent Portal-BarraultChief Operating OfficerTess PalmerDirector of Investor RelationsMr. Clayton John McCormack B.Com.L.L.B., Company Secretary & General CounselNavleen PrasadPublic Affairs ManagerJim DicksonCorporate Development & Strategy ExecutiveMs. Catherine BrainGroup Executive of People & CultureMr. Paul Lynch B.Com.L.L.B., Joint Company SecretaryMr. Ryan Reynolds C.F.A.Specialist of Forecasting and AnalysisMore ExecutivesKey CompetitorsFerrovialOTCMKTS:FERVFPARK24OTCMKTS:PKCOYPromotora y Operadora de Infraestructura, S. A. B. de C. V.OTCMKTS:PYOIFPromotora y Operadora de Infraestructura, S. A. B. de C. V.OTCMKTS:PUODYTransurban GroupOTCMKTS:TRAUFView All Competitors MAQAF Stock Analysis - Frequently Asked Questions Should I buy or sell Atlas Arteria stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Atlas Arteria in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MAQAF shares. View MAQAF analyst ratings or view top-rated stocks. How have MAQAF shares performed in 2024? Atlas Arteria's stock was trading at $3.95 at the beginning of 2024. Since then, MAQAF shares have decreased by 5.8% and is now trading at $3.72. View the best growth stocks for 2024 here. Are investors shorting Atlas Arteria? Atlas Arteria saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,331,000 shares, an increase of 28.1% from the April 15th total of 1,820,200 shares. Based on an average trading volume of 2,300 shares, the short-interest ratio is currently 1,013.5 days. View Atlas Arteria's Short Interest. Is Atlas Arteria a good dividend stock? Atlas Arteria (OTCMKTS:MAQAF) pays an annual dividend of $0.08 per share and currently has a dividend yield of 5.02%. MAQAF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. How do I buy shares of Atlas Arteria? Shares of MAQAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MAQAF) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlas Arteria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
